This summary was created by AI, based on 3 opinions in the last 12 months.
Boston Scientific Corp (BSX-N) has been a top pick and a top performer, with a venture capital fund in the health care business expecting consistent gains going forward. The stock has shown growth above its fair market value, and while it is currently at a new high in terms of price, it still has room for growth. However, experts also note a 25% downside risk and the lack of yield, making it a bouncy kind of stock with a fairly nice growth potential.
Above FMV of $40 by 22%. Growth is fairly nice. He thinks it will hold fairly well. A bouncy kind of stock.
It is at a new high in terms of price but not new highs in terms of Price/Book. There is no yield and a 25% downside risk.
It is a leader in the field so the price is at a premium for a good reason. Has had a good bounce. You could also look at MedTech and Thermo-Fisher.
Boston Scientific Corp is a American stock, trading under the symbol BSX-N on the New York Stock Exchange (BSX). It is usually referred to as NYSE:BSX or BSX-N
In the last year, 4 stock analysts published opinions about BSX-N. 2 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Boston Scientific Corp.
Boston Scientific Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Boston Scientific Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
4 stock analysts on Stockchase covered Boston Scientific Corp In the last year. It is a trending stock that is worth watching.
On 2024-04-24, Boston Scientific Corp (BSX-N) stock closed at a price of $72.91.
Still owns shares. Venture capital fund in health care business. One of most successful funds in biotech. Expecting consistent gains going forward.